Corporate Accountability
Pundits Predict: King v. Burwell
…Simon Lazarus, JD, senior counsel for the Constitutional Accountability Center, who also spoke at the briefing, said that Justice Kennedy shifted the entire legal argument of the case when he interpreted the challenger’s case to mean that the authors of the bill intended for the provision to punish states.
Lazarus quoted Kennedy, who said, “Such a threat could amount to unconstitutional ‘coercion’ to force states to set up exchanges.”
If Kennedy’s perspective holds, Lazarus said “the most likely result” is a decision in the administration’s favor on the basis of “constitutional avoidance,” which he defined as a rule that says federal law should be followed in a way that “avoids raising difficult constitutional questions.”…
More from Corporate Accountability
September 9, 2025
ENFORCEMENT ACTIONS—Fifth Circuit rejects petition challenging OCC authority to enforce national banking rules
The court distinguished the national banking regulatory regime from the SEC’s antifraud provision in Jarkesy and the...
July 11, 2025
This Group’s Record in Front of the Roberts Court Is Mind-Boggling
In a provocative dissenting opinion, Justice Ketanji Brown Jackson recently called out her colleagues on the Supreme Court...
July 2, 2025
Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)
The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
U.S. Court of Appeals for the Third Circuit
Novartis v. Secretary United States Department of Health and Human Services
In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
January 28, 2025
Federal Deposit Insurance as Jarkesy Waiver
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
U.S. Court of Appeals for the Second Circuit
Boehringer Ingelheim v. Department of Health and Human Services
In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking...